Arete Wealth Advisors’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-15,000
| Closed | -$46K | – | 708 |
|
|
2024
Q2 | $46K | Buy |
+15,000
| New | +$46K | ﹤0.01% | 707 |
|
|
2024
Q1 | – | Sell |
-15,000
| Closed | -$37.5K | – | 379 |
|
|
2023
Q4 | $37.5K | Hold |
15,000
| – | – | ﹤0.01% | 722 |
|
|
2023
Q3 | $30.5K | Hold |
15,000
| – | – | 0.01% | 488 |
|
|
2023
Q2 | $35K | Hold |
15,000
| – | – | ﹤0.01% | 650 |
|
|
2023
Q1 | $45K | Buy |
+15,000
| New | +$45K | ﹤0.01% | 622 |
|
|
2022
Q4 | – | Sell |
-15,000
| Closed | -$29K | – | 633 |
|
|
2022
Q3 | $29K | Buy |
+15,000
| New | +$29K | ﹤0.01% | 564 |
|
|
2022
Q2 | – | Sell |
-15,000
| Closed | -$45K | – | 453 |
|
|
2022
Q1 | $45K | Hold |
15,000
| – | – | ﹤0.01% | 500 |
|
|
2021
Q4 | $58K | Buy |
+15,000
| New | +$58K | ﹤0.01% | 494 |
|